Almirall stock after-hours at EUR 10.23: plus 0.20 percent versus prior close
Published on 10/02/2026 at 20:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Almirall traded at EUR 10.23 after-hours at 8:08 p.m. CEST on October 2, 2026, up 0.20 percent versus the prior close at Lang & Schwarz of EUR 10.21.
Trading day in focus
The Lang & Schwarz quote showed an increase of EUR 0.02 from the prior close. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Almirall stock.
New evidence at EADV 2026
Business Wire reported that Almirall, S.A. presented a scientific program at the 35th European Academy of Dermatology and Venereology Congress in Vienna, which runs from September 30 to October 3, 2026. The program covers atopic dermatitis, psoriasis and actinic keratosis, with clinical and real-world evidence across the company’s dermatology portfolio.
In a separate Business Wire release, Almirall said results from the Phase 3b ADlong extension study showed sustained outcomes through week 108 among patients receiving lebrikizumab for moderate-to-severe atopic dermatitis. At that assessment, 92.9 percent achieved an EASI-75 response, 73.8 percent achieved EASI-90, and 78.0 percent reported a pruritus score of four or less. The company said the safety profile was consistent with previous studies and that no new safety signals were identified.
